Entity Setup
Structuring a Business Entity in Canada for R&D Incentives: What You Need to Know for SR&ED
Canada’s enhanced SR&ED credits and CCA changes present an opportunity: choosing the right entity structure dramatically affects eligibility and benefit levels.
By NomadicTax Research Team • 5-8 min read • November 23, 2025
## Introduction
Canada has recently strengthened its **Scientific Research & Experimental Development (SR&ED)** regime: CCPCs (Canadian-controlled private corporations) can now claim an **enhanced 35% investment tax credit** on a higher threshold of expenditures and public corporations may also qualify. ([canada.ca](https://www.canada.ca/en/revenue-agency/services/tax/businesses/topics/corporations/whats-new-corporations.html?utm_source=openai))
For investors, startup founders and biotech firms, structuring your entity carefully can **unlock substantial tax savings** and maximize liquidity.
## Key enhancements – what’s new?
- **Annual expenditure limit** for CCPCs increased from **$3M to $4.5M** for enhanced SR&ED ITC. ([canada.ca](https://www.canada.ca/en/revenue-agency/services/tax/businesses/topics/corporations/whats-new-corporations.html?utm_source=openai))
- **Taxable capital thresholds** raised: prior-year caps increased to $15M and $75M. The phase-outs apply beyond those thresholds. ([canada.ca](https://www.canada.ca/en/revenue-agency/services/tax/businesses/topics/corporations/whats-new-corporations.html?utm_source=openai))
- **Inclusion of public corporations**: public companies can now access SR&ED enhanced refundable credits. ([canada.ca](https://www.canada.ca/en/revenue-agency/services/tax/businesses/topics/corporations/whats-new-corporations.html?utm_source=openai))
- **Capital costs pre-2014 eligibility reinstated** for property acquired after December 15, 2024. This affects older fixed assets eligible for CCA and SR&ED income deduction. ([canada.ca](https://www.canada.ca/en/revenue-agency/services/tax/businesses/topics/corporations/whats-new-corporations.html?utm_source=openai))
## Entity setup matters – structuring for optimal benefit
| Scenario | CCPC vs non-CCPC | Public vs Private | Age/Type of property/assets |
|---|---|---|---|
| A startup rooted in Canada with private shareholders | Best as a **CCPC** to get full enhanced credit (35%) | N/A | New property acquired after Dec 15, 2024 benefits from reinstated eligibility |
| Expanding or listed company | If you lose CCPC status (public or taxable capital too high), credit begins phasing out | Public corporations now have refundable portion – still beneficial | Ensure assets meet new eligibility rules under pre-2014 regime reinstatement |
## Practical actions & planner checklist
- **Ensure corporate structure meets CCPC requirements**: be Canadian-controlled, private, shareholders domestic, etc. Otherwise, credits may reduce or disappear.
- **Track taxable capital** carefully**: large assets or growth in capital may push you over the thresholds prematurely.
- **Time asset acquisitions**: property acquired after Dec 15, 2024 gains extra eligibility. If possible, accelerate purchases to qualify.
- **Maintain R&D records meticulously**: lab notes, experimental designs, expenses. For public corporations, refundability is especially important—ensure documentation supports refund claims.
- **Consider public-vs-private status trade-offs**: if raising capital via IPO, weigh loss of CCPC status vs refundable credits access.
## Example case study
**Biotech Startup “BioNova Inc.”**
BioNova is a private, CCPC located in Ontario. It plans $5M of SR&ED eligible expenditures this fiscal year. Under the new rules, up to **$4.5M** of that qualifies for a 35% credit, yielding ~$1.575M in credit on that portion. The extra $0.5M still receives credit, but possibly at lower rate or reduced phase-out. They avoid losing CCPC status by keeping taxable capital within threshold. If instead they go public, they still qualify, but will use refundable portion and likely different phase-outs.
## Risks and compliance traps
- Overestimating eligible expenditures: ensure activities meet SR&ED criteria.
- Losing CCPC status due to public shareholders or capital: can reduce benefit rates.
- Missing deadlines: claims must follow CRA rules, asset availability dates matter.
- Underreporting capital cost basis or misunderstanding eligibility of older assets.
## Conclusion
If you're considering entity formation or restructuring in Canada, recent changes in SR&ED regime demand attention. With strategic structuring—focusing on CCPC status, timing of asset acquisitions, and proper capital management—you can significantly increase your tax benefit while staying compliant.